Prescription Digital Therapeutics

March 08, 2023

The development comes after a study showed users had four fewer days per month with migraine symptoms.

March 07, 2023

By clustering patients based on self-reported data, investigators said they may be able to predict which patients are most likely to respond to a digital therapy.

March 06, 2023

The goal of the application programming interface (API) is to ensure accurate data collection without burdening patients or biasing the data.

February 17, 2023

Leaders of the Digital Therapeutics Alliance hope to get a Congressional Budget Office score on the legislation that would extend Medicare coverage so members of Congress can weigh budget implications.

February 16, 2023

Digital therapeutics are regulated like devices by the FDA. Andy Molnar, the CEO of the industry’s trade organization, the Digital Therapeutics Alliance, says the FDA clearance and authorization process for digital therapeutics “works.”

February 15, 2023

A new study showed a smartphone app is associated with improvements in HbA1c levels and other measurements indicative of well-managed diabetes. The authors note, though, that benefit may come from greater physician involvement with patients and other factors related to the app.

February 14, 2023

The trade association began lobbying in 2019.

February 09, 2023

Digital therapies for migraine have been studied extensively in recent years, and the number of products on the market is likely to expand.

January 18, 2023

Developer of EndeavorRx, a game-based treatment for ADHD, is pulling back from the pipeline and focusing on near-term growth, the CEO said in an email to employees.

January 18, 2023

Pear also recently announced a deal with California's Medicaid program that involves supporting a pilot project to help people with stimulant use disorder.